Leadership Overview
Divi's Laboratories has 6 executives leading key functions including strategy, operations, finance, information technology, and nutraceuticals.
Driven by a commitment to quality and innovation, Divi's Laboratories specializes in custom synthesis of generic APIs, intermediates, and nutraceutical ingredients, impacting global pharmaceutical markets from its base in India.
Driven by a commitment to quality and innovation, Divi's Laboratories specializes in custom synthesis of generic APIs, intermediates, and nutraceutical ingredients, impacting global pharmaceutical markets from its base in India.
Leadership Roles at Divi's Laboratories
Kiran Divi - Chief Executive Officer
Kiran Divi, the Chief Executive Officer at Divi's Laboratories, directs the company's overarching strategic vision and operational execution. Overseeing all major business units, Kiran Divi ensures alignment with the company's mission to produce high-quality generic APIs, intermediates, and nutraceutical ingredients. This leadership role involves driving innovation in custom synthesis processes and expanding market reach within the global pharmaceutical sector. By fostering a culture of excellence, Kiran Divi guides the organization in maintaining its competitive edge and delivering value to stakeholders. The Chief Executive Officer's responsibilities encompass financial oversight, resource allocation, and long-term business development, all critical to the company's sustained growth and market leadership in India and beyond.
Veeranjaneyulu Vallepu - Co-Chief Executive Officer
Veeranjaneyulu Vallepu, the Co-Chief Executive Officer at Divi's Laboratories, shares responsibility for the company's strategic direction and operational management. Veeranjaneyulu Vallepu focuses on optimizing manufacturing processes for generic APIs and intermediates, ensuring efficiency and adherence to stringent quality standards. This executive collaborates closely with other leadership to drive the company's expansion in key international markets. The Co-Chief Executive Officer's role involves managing cross-functional teams to enhance production capabilities and streamline supply chain logistics. By championing operational excellence, Veeranjaneyulu Vallepu contributes significantly to Divi's Laboratories' reputation for reliability and its ability to meet diverse client needs in the pharmaceutical industry. This leadership position is vital for maintaining robust production output and fostering sustainable business practices.
Kishorebabu Lingamneni - Chief Financial Officer
Kishorebabu Lingamneni, the Chief Financial Officer at Divi's Laboratories, manages the company's financial operations and fiscal strategy. Kishorebabu Lingamneni oversees all aspects of financial planning, budgeting, and reporting, ensuring the company's financial stability and compliance with regulatory requirements. This role involves managing capital allocation, optimizing investment strategies, and mitigating financial risks associated with global operations. The Chief Financial Officer's responsibilities extend to driving financial performance, enhancing profitability, and supporting strategic decision-making through rigorous financial analysis. By maintaining sound financial practices, Kishorebabu Lingamneni ensures Divi's Laboratories can effectively fund its research, development, and manufacturing initiatives, contributing to its sustained growth and market position in the pharmaceutical sector.
Anirudh Nimmagadda - President (Nutraceuticals)
Anirudh Nimmagadda, the President (Nutraceuticals) at Divi's Laboratories, spearheads the strategic direction and operational management of the company's nutraceutical division. Anirudh Nimmagadda focuses on expanding the product portfolio and market presence for nutraceutical ingredients, ensuring high standards of quality and efficacy. This leadership role involves driving innovation in product development, managing supply chain logistics specific to nutraceuticals, and fostering relationships with key clients and partners in this specialized sector. The President (Nutraceuticals) works to enhance the division's profitability and market share, contributing significantly to Divi's Laboratories' overall business objectives. By overseeing this critical segment, Anirudh Nimmagadda ensures the company's continued success in delivering high-value nutraceutical solutions.
Manoranjan Jasti - Chief Information Officer
Manoranjan Jasti, the Chief Information Officer at Divi's Laboratories, leads the company's information technology strategy and infrastructure. Manoranjan Jasti is responsible for implementing and managing robust IT systems that support the manufacturing of generic APIs, intermediates, and nutraceutical ingredients, ensuring data security and operational efficiency. This executive oversees the integration of advanced technologies to enhance business processes, streamline operations, and support research and development initiatives. The Chief Information Officer's role involves driving digital transformation, managing cybersecurity protocols, and ensuring the reliability of all IT services across the organization. By leveraging technology, Manoranjan Jasti enables Divi's Laboratories to maintain a competitive advantage and adapt to the evolving demands of the pharmaceutical industry.
Murali Divi - Managing Director
Murali Divi, the Managing Director at Divi's Laboratories, provides critical leadership in steering the company's long-term growth and strategic initiatives. Murali Divi oversees the development and implementation of business strategies aimed at expanding the company's portfolio of generic APIs, intermediates, and nutraceutical ingredients. This executive is instrumental in forging key partnerships and exploring new market opportunities, particularly within the competitive Indian pharmaceutical landscape and globally. The Managing Director's responsibilities include ensuring robust corporate governance, driving research and development efforts, and maintaining the company's financial health. By guiding strategic planning and operational oversight, Murali Divi ensures Divi's Laboratories remains at the forefront of pharmaceutical manufacturing innovation and market responsiveness.
Explore Leadership Teams in Manufacturing
Bayer is a global enterprise in the life science fields of healthcare and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. They have divisions in pharmaceuticals, crop science, animal health, and consumer health. Bayer is headquartered in Leverkusen, Germany.
Company Leadership JL
LS
JW
Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA is a multinational pharmaceutical, chemical and life sciences company. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing.
Company Leadership BZ
LB
AB
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Company Leadership CK
KP
Eris Lifesciences Ltd is a prominent Indian pharmaceutical company specializing in branded formulations, particularly in the cardio-metabolic sector. The company offers a diverse range of products across various therapeutic areas including anti-diabetes, cardiovascular health, dermatology, and gynecology. Eris is committed to improving patient care through innovative initiatives and pioneering studies aimed at chronic lifestyle-related diseases. Their target clients include healthcare professionals and patients across India, with a focus on enhancing health outcomes.
Company Leadership VK
MM
GA
Frequently Asked Questions Regarding Divi's Laboratories Top Executives and Leadership Team
